Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−16.8054 USD
−11.65 M USD
0.00 USD
2.61 M
About AVENUE THERAPEUTICS INC
Sector
Industry
CEO
Alexandra MacLean
Website
Headquarters
Bay Harbor Islands
Founded
2015
FIGI
BBG00GLTS587
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of ATXI is 0.2663 USD — it has increased by 2.40% in the past 24 hours. Watch AVENUE THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange AVENUE THERAPEUTICS INC stocks are traded under the ticker ATXI.
ATXI stock has risen by 6.44% compared to the previous week, the month change is a −65.86% fall, over the last year AVENUE THERAPEUTICS INC has showed a −99.97% decrease.
ATXI reached its all-time high on Sep 14, 2020 with the price of 15,617,642.6641 USD, and its all-time low was 0.2500 USD and was reached on Apr 2, 2025. View more price dynamics on ATXI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ATXI stock is 21.15% volatile and has beta coefficient of 0.76. Track AVENUE THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is AVENUE THERAPEUTICS INC there?
Today AVENUE THERAPEUTICS INC has the market capitalization of 838.83 K, it has decreased by −12.07% over the last week.
Yes, you can track AVENUE THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
AVENUE THERAPEUTICS INC is going to release the next earnings report on May 19, 2025. Keep track of upcoming events with our Earnings Calendar.
ATXI net income for the last quarter is −1.54 M USD, while the quarter before that showed −3.08 M USD of net income which accounts for 49.80% change. Track more AVENUE THERAPEUTICS INC financial stats to get the full picture.
No, ATXI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 2 employees. See our rating of the largest employees — is AVENUE THERAPEUTICS INC on this list?
Like other stocks, ATXI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AVENUE THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AVENUE THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AVENUE THERAPEUTICS INC stock shows the sell signal. See more of AVENUE THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.